Dermata Therapeutics, Inc. (DRMA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.24
Day's range
$1.33

Dermata Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 20.20 K $26.06 K   -58.20% 0.50%
WELCH & FORBES LLC 07/30/2026 20.00 K $25.80 K   0.00% 0.50%
STATE STREET CORP 09/22/2026 18.75 K $24.18 K   100.00% 0.47%
UBS GROUP AG 08/13/2026 16.80 K $21.67 K   -52.83% 0.42%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 15.99 K $20.63 K   100.00% 0.40%
XTX TOPCO LTD 08/14/2026 14.79 K $19.08 K   100.00% 0.37%
ADVISORY ALPHA, LLC 08/11/2026 10.00 K $12.90 K   100.00% 0.25%
TOWER RESEARCH CAPITAL LLC (TRC) 08/11/2026 3.86 K $4.98 K   439.11% 0.10%
MCF ADVISORS LLC 08/12/2026 1.73 K $2.24 K   0.00% 0.04%
BARCLAYS PLC 08/14/2026 270 $348   100.00% 0.01%
SBI SECURITIES CO., LTD. 07/23/2026 101 $130   0.00% 0.00%
HIGHLINE WEALTH PARTNERS LLC 07/15/2026 26 $34   100.00% 0.00%
MORGAN STANLEY 08/13/2026 2 $3   100.00% 0.00%
CITIGROUP INC 08/03/2026 0 $0   -100.00% 0.00%

Dermata Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 14 institutional investors and hedge funds held shares of Dermata Therapeutics Inc. The most heavily invested institutionals were:

GEODE CAPITAL MANAGEMENT, LLC: 20,203

WELCH & FORBES LLC: 20,000

STATE STREET CORP: 18,747

UBS Group AG: 16,796

SUSQUEHANNA INTERNATIONAL GROUP, LLP: 15,989

XTX Topco Ltd: 14,787

3.05% of Dermata Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 122.51 K shares in the last 24 months. This purchase volume represents approximately $162.94 K in transactions.